Preparation method of deer placenta polypeptide oral liquid with anti-aging effect
By protease hydrolysis and freeze-drying of the deer placenta polypeptide powder, combined with yeast deodor fishy and adding honey, the oral liquid of deodor placenta polypeptide with anti-aging effects was prepared, which solved the problem of taste and anti-aging effects and achieved the product high extraction rate and stability.
Patent Information
- Application Number
- CN202411094584.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-10
- Publication Date
- 2024-11-26
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art is difficult to provide a method for preparing a deer placenta polypeptide oral solution with a good taste and anti-aging effect.
By drying and grinding the deer placenta into powder, performing protease hydrolysis, heating and dezygating enzymes, freeze-dried deer placenta polypeptides, then preparing it into a solution and de-fishing through yeast, honey, xanthan gum and sodium benzoate are added, After mixing evenly, oral liquid of deer placenta polypeptide was obtained, and filled and sterilized.
It has achieved the preparation of deer placenta polypeptide oral liquid with good outlet and easy absorption, with high extraction rate and significant anti-aging effects, high product stability, and is suitable for large-scale production and use.
Smart Images

Figure CN119014548A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of biopharmaceuticals, and in particular to a method for preparing a deer placenta polypeptide oral liquid having antioxidant and anti-aging effects, namely, a method for preparing a deer placenta polypeptide oral liquid. Background Art
[0002] Placenta has immune enhancement, antioxidant, anti-inflammatory activities and various applications in chronic diseases, pain, paralysis, osteoporosis, fatigue and cosmetics. Placenta extract can improve menopausal symptoms, fatigue and liver function, and contains physiologically active substances with antioxidant, anti-inflammatory and analgesic effects. Deer placenta is sweet, salty and warm in nature, and can enter the liver, kidney and heart meridians. Chinese medicine believes that the placenta has the effects of regulating qi and blood, nourishing yin and nourishing beauty. In ancient prescriptions, deer placenta, black chicken and donkey-hide gelatin are collectively called "three treasures". Bioactive peptides are short amino acid sequences with specific physiological functions, which have the effect of affecting human health and preventing the development of various diseases. Bioactive peptides promote many functions of metabolism and physiological regulation, such as promoting digestion and absorption, improving immunity, hormone regulation, antibacterial effect, antiviral effect, lowering blood pressure, softening blood vessels and delaying aging. Deer placenta polypeptides have been shown to have sedative effects, in vitro anti-lipid oxidation effects and immunity-enhancing effects. It can be used as a new item for diagnosing, treating or preventing various human diseases.
[0003] Deer placenta peptides are rich in hydrophobic amino acids, such as Val, Leu, Ala, Ile, Pro, Phe, Trp and Met. Hydrophobic amino acids can increase the affinity of peptides in the fat phase, thereby promoting the acquisition of free radicals generated in the fat phase. Due to its strong antioxidant activity and safety, it is widely used in the food industry and medical products. Deer placenta peptides have a low molecular weight and are easily absorbed by the human body. They are often taken orally to exert beneficial effects on the skin, cartilage and bone. Therefore, they are often used in the development of functional foods and dietary supplements, and are widely used in daily foods, functional foods and special dietary foods. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a method for preparing a deer placenta peptide oral liquid with good taste and anti-aging effect. The technical solution adopted to solve the above technical problem is a method for preparing a deer placenta peptide oral liquid with anti-aging effect, which specifically comprises the following steps:
[0005] S1: drying and grinding the deer placenta to obtain deer placenta powder, and adding protease to the deer placenta powder for hydrolysis;
[0006] S2: After the hydrolysis is completed, the temperature is increased to 95°C to inactivate the enzyme;
[0007] S3: freeze-drying the hydrolyzate to obtain freeze-dried deer placenta polypeptide powder, and storing it;
[0008] S4: preparing the above-mentioned deer placenta polypeptide freeze-dried powder into a solution, adding yeast to remove the fishy smell, and obtaining a target solution;
[0009] S5: adding honey to the target solution obtained in S4 to correct the taste, adding xanthan gum, disodium ethylenediaminetetraacetic acid, and sodium benzoate, and mixing evenly to obtain a deer placenta polypeptide oral solution;
[0010] S6: Filling and sterilizing the deer blood polypeptide oral liquid to obtain a finished oral liquid.
[0011] In step S1, the weight ratio of the deer fetus powder to the distilled water is 1:10-500. The amount of the hydrolase added is 400-800 U / g. In step S2, the enzyme inactivation temperature is 95°C-100°C.
[0012] In step S3, the freeze-drying is carried out in a freeze-dryer, and the freeze-drying time is 8 to 48 hours.
[0013] In step S4, the concentration of yeast is 1.0%-5.0%, the yeast deodorization temperature is 30-60°C, and the deodorization time is 15-45 minutes.
[0014] In step S5, 5%-10% honey is added for flavor correction, 0.1%-0.5% sodium carboxymethyl cellulose stabilizer is added, and 0.1%-0.3% sodium benzoate is added.
[0015] In step S6, the sterilization method may be 0.22 μm filter membrane filtration, high pressure sterilization, etc.
[0016] The present invention has the following beneficial effects:
[0017] The deerskin collagen polypeptide oral liquid of the present application has a simple preparation process, is easy to take, has a high extraction rate and good efficacy. During the production process, the effective ingredients in the deer placenta are extracted to the maximum extent and the stability of the product is guaranteed. The deer placenta polypeptide oral liquid of the present application has an anti-aging effect. At the same time, the deer placenta polypeptide extract prepared by the enzymatic hydrolysis method adopted in the present application is easily absorbed by the human body, thereby better exerting the anti-aging effect of the product. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In order to more clearly illustrate the solutions in the present application, the following is a brief introduction to the drawings required for use in the description of the embodiments of the present application. Obviously, the drawings described below are some embodiments of the present application.
[0019] Figure 1 The present invention is a flow chart of an embodiment of the method for preparing the deer placenta polypeptide oral liquid.
[0020] Figure 2The deer placenta polypeptide of the present application affects the viability of HepG2 cells.
[0021] Figure 3 This is based on the effect of the deer placenta polypeptide of the present application on the H2O2-induced HepG2 cell viability.
[0022] Figure 4 The invention relates to the effect of the deer placenta polypeptide of the present application on the weight change of aging mice induced by D-galactose.
[0023] Figure 5 The present invention is based on the deer placenta polypeptide of the present application for the histopathological analysis of liver tissues of aging mice induced by small D-galactose.
[0024] Figure 6 The invention relates to a histopathological analysis of kidney tissues of aging mice induced by small D-galactose by deer placental polypeptides of the present application. DETAILED DESCRIPTION
[0025] The present invention will be described in more detail below through specific embodiments, but the protection scope of the present invention is not limited to these embodiments.
[0026] Example 1
[0027] In this embodiment, the steps are as follows: add deer placenta powder to distilled water to prepare a solution, add hydrolase to start the hydrolysis reaction, wherein the weight ratio of deer placenta powder to distilled water is 1:200, and the amount of compound enzyme added is 800U / g. After hydrolysis, the enzyme is inactivated by boiling water. The hydrolyzate is freeze-dried using a freeze dryer for 48 hours. After freeze drying, the deer placenta polypeptide is obtained and stored at low temperature. Yeast, honey, disodium ethylenediaminetetraacetic acid and sodium benzoate are added. After sealing, the deer placenta polypeptide oral liquid is obtained.
[0028] The preparation process of deer placenta polypeptide oral solution is as follows Figure 1 shown.
[0029] Example 2
[0030] In this example, the effect of deer placenta polypeptide on the cell viability of HepG2 cells was detected in the following steps:
[0031] The cell viability was determined by the CCK8 method. HepG2 cells were seeded in a 96-well plate at 2.0×103 cells per well. DPP sample solutions were prepared at concentrations of 0, 5, 10, 20, 40, 80, 160, and 200 μg / mL. 0% DMEM high-glucose medium was added to the blank group, and different concentrations of DPP sample solutions were added to the culture wells of the DPP group. After incubation for 24 hours, CCK8 solution was added to each well. After incubation for 2 hours in the dark, the absorbance was measured at 450 nm by an ELISA reader. Figure 2This is a graph showing the effect of the deer placenta polypeptide of the present application on the cell viability of HepG2 cells.
[0032] from Figure 2 It can be seen that after the HepG2 cells were treated with a polypeptide at a concentration of 0 to 200 μg / mL for 24 hours, when the polypeptide concentration was in the range of 0 to 160 μg / mL, the polypeptide did not cause any cytotoxic effect.
[0033] Example 3
[0034] In this example, the effect of deer placenta polypeptide on the cell viability of HepG2 cells induced by H2O2 was detected, and the steps were as follows:
[0035] The cell viability was determined by CCK8 method. The protective effect of DPP on H2O2-induced HepG2 cells was divided into 5 groups: control group (N), model group (M), low-dose polypeptide group (DL), medium-dose polypeptide group (DM) and high-dose polypeptide group (DH). 1.5mmol / L H2O2 solution was prepared for the model group, and 400, 800 and 1600μg / ml DPP were prepared for the treatment group.
[0036] Figure 3 This is a graph showing the cytotoxicity of the deer placenta polypeptide of the present application to H2O2-induced HepG2 cells. Figure 3 It can be seen that deer placenta polypeptide treatment significantly improved the decrease in HepG2 cell viability caused by H2O2.
[0037] Example 4
[0038] In this example, the effect of deer placenta polypeptide on the body weight of aging mice was detected, and the steps were as follows:
[0039] 60 male Kunming mice were selected and divided into 6 groups, with 10 mice in each group. D-galactose was started after 7 days of free food and water intake. The 60 mice were randomly divided into 6 groups (normal control group, model group, low-dose group, medium-dose group and high-dose group), with 10 mice in each group. 0.2 mL was administered by gavage every day, and the blank control group was gavaged with the same dose of normal saline, and the weight changes of the mice were monitored.
[0040] Figure 4 This is a graph showing the effect of deer placenta polypeptide on the weight change of D-galactose-induced aging mice according to the present application. Figure 4 It can be seen that there was no significant difference in the average body weight between the groups at the beginning of the experiment compared with the mice in the N group. However, after 8 weeks of D-galactose treatment, the average body weight of the model M group was significantly lower than that of normal mice. After administration of DPP, the trend of weight loss in D-galactose-induced aging mice was significantly reversed.
[0041] Example 5
[0042] In this example, the effect of deer placenta polypeptide on liver pathology of D-galactose-induced aging mice was detected, and the steps were as follows:
[0043] Liver tissues were obtained from mice after being killed. Fresh liver tissues of mice were fixed in formalin fixative. After dehydration, embedding, slicing, dewaxing, staining, dehydration and sealing, microscopic examination and image acquisition and analysis were performed.
[0044] Figure 5 This is a graph showing the effect of deer placenta polypeptide on liver pathology in D-galactose-induced aging mice according to the present application. Figure 5 It can be seen that deer placenta polypeptide effectively alleviated the changes in liver tissue morphology caused by oxidative damage and normalized the liver tissue morphology induced by oxidative damage in mice.
[0045] Example 6
[0046] In this example, the effect of deer placenta polypeptide on renal pathology of D-galactose-induced aging mice was detected, and the steps were as follows:
[0047] Liver tissues were obtained from mice after being killed. Fresh liver tissues of mice were fixed in formalin fixative. After dehydration, embedding, slicing, dewaxing, staining, dehydration and sealing, microscopic examination and image acquisition and analysis were performed.
[0048] Figure 6 This is a graph showing the effect of deer placenta polypeptide on renal pathology in D-galactose-induced aging mice according to the present application. Figure 6 It can be seen that deer placenta polypeptide effectively alleviated the changes in kidney tissue morphology caused by oxidative damage and normalized the kidney tissue morphology induced by oxidative damage in mice.
[0049] In summary, through the protective effect of deer placenta polypeptide on aging cells and animals, the above experimental results prove that the deer placenta polypeptide oral liquid has a good anti-aging effect.
[0050] The beneficial effects of this application are as follows:
[0051] 1. Simple prescription process to meet large-scale production
[0052] By optimizing the production steps, we have achieved simple and easy large-scale production while ensuring the nutritional value of deer placenta polypeptide. At the same time, the prepared deer placenta polypeptide oral liquid has the advantages of less loss of nutrients and easier absorption.
[0053] 2. Compared with similar products, it has better anti-aging effect
[0054] The prepared deer placenta polypeptide oral liquid is easily absorbed by the intestine, which improves the bioavailability, thereby improving the product efficacy and having better anti-aging effect.
[0055] 3. The product is easy to carry, nutritious and delicious
[0056] The product is finally prepared into an oral liquid with good taste and flavor, and is convenient to eat and carry. The product is a good nutritional product with high biological activity.
[0057] In summary, the deer placenta polypeptide oral liquid of the present application has a simple preparation process, is easy to take, has a high extraction rate, and has good efficacy.
Claims
1. A method for preparing a deer placenta polypeptide oral liquid with anti-aging effect, characterized in that: The steps include: S1: adding the composite protease to the deer placenta powder to start hydrolysis, thereby obtaining the deer placenta polypeptide solution; S2: After the deer placenta polypeptide solution is hydrolyzed, the enzyme is inactivated at 95°C; S3: freeze-drying the deer placenta polypeptide hydrolyzate to obtain a deer placenta polypeptide freeze-dried powder, and storing the powder; S4: preparing the above-mentioned deer placenta polypeptide freeze-dried powder into a solution, adding yeast to remove the fishy smell, and obtaining a target solution; S5: adding honey to the target solution obtained in S4 to correct the taste, adding xanthan gum, disodium ethylenediaminetetraacetic acid, and sodium benzoate, and mixing evenly to obtain a deer placenta polypeptide oral solution; S6: Filling and sterilizing the deer blood polypeptide oral liquid to obtain a finished oral liquid product.
2. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: In step S1, the weight ratio of the deer fetus powder to the distilled water is 1:10-500, and the amount of the hydrolase added is 400-800 U / g.
3. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: In step S2, the enzyme inactivation temperature is 95°C-100°C.
4. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: In step S3, the freeze-drying is carried out in a freeze-dryer, and the freeze-drying time is 8 to 24 hours.
5. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: In step S4, the concentration of yeast is 1.0%-5.0%, the yeast deodorization temperature is 30-60°C, and the deodorization time is 15-45 minutes.
6. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: In step S5, 5%-10% honey is added for flavor correction, 0.1%-0.5% sodium carboxymethyl cellulose stabilizer is added, and 0.1%-0.3% sodium benzoate is added.
7. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: In step S6, the sterilization method may be 0.22 μm filter membrane filtration, high pressure sterilization, etc.
8. A deer placenta polypeptide oral liquid prepared by the preparation method according to any one of claims 1 to 7.
9. The method for preparing a deer placenta polypeptide oral liquid with anti-aging effect according to claim 1, characterized in that: The deer placenta polypeptide oral liquid has a good application in anti-aging effects.
Citation Information
Patent Citations
Enzyme hydrolysis method for preparing fetus cervi active peptide
CN102925523A
Sheep placenta polypeptide as well as preparation method and application thereof
CN114592024A
Preparation method of deer skin collagen polypeptide oral liquid with anti-aging effect
CN116530691A
Preparation method of deer blood polypeptide oral liquid with immunoregulation function
CN116548623A
Method for preparing physiological active polypeptide of deer placenta
CN1891711A
Cited By
Deer peptide compound preparation as well as preparation method and application thereof
CN120531845A
